| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11926-008-0074-X |
| P698 | PubMed publication ID | 19007535 |
| P2093 | author name string | Rafael G Grau | |
| P2860 | cites work | Nomenclature of systemic vasculitides. Proposal of an international consensus conference | Q29616304 |
| Etanercept plus standard therapy for Wegener's granulomatosis | Q33984596 | ||
| The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). | Q34226979 | ||
| Churg-Strauss syndrome: update on recent developments | Q34493888 | ||
| Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. | Q35553628 | ||
| Circulating endothelial cells in relapse and limited granulomatous disease due to ANCA associated vasculitis. | Q35636746 | ||
| Acute coronary syndrome associated with Churg-Strauss syndrome. | Q36536247 | ||
| Treatment for Churg-Strauss syndrome: induction of remission and efficacy of intravenous immunoglobulin therapy | Q36802256 | ||
| Central retinal artery occlusion in an ANCA negative Churg-Strauss syndrome patient | Q36830730 | ||
| Churg-Strauss syndrome: just one disease entity? | Q81162516 | ||
| Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma | Q81542034 | ||
| Nonsystemic vasculitic neuropathy: a clinicopathological study of 22 cases | Q82704617 | ||
| Renal involvement in Churg-Strauss syndrome | Q83188529 | ||
| Cardiac involvement in the Churg-Strauss syndrome | Q83297085 | ||
| Prevalence of Wegener's granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. | Q36842283 | ||
| Targeting B lymphocytes as therapy for ANCA-associated vasculitis | Q37013674 | ||
| Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. | Q40170990 | ||
| Discoidin domain receptor 1 contributes to eosinophil survival in an NF-kappaB-dependent manner in Churg-Strauss syndrome | Q40232926 | ||
| Churg-Strauss syndrome presenting with massive pericardial effusion. | Q40454282 | ||
| Churg-Strauss syndrome associated with leukotriene receptor antagonists (LTRA). | Q40459084 | ||
| Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome | Q40494956 | ||
| Elevated interleukin-4 and interleukin-13 production by T cell lines from patients with Churg-Strauss syndrome | Q40823074 | ||
| Coronary involvement in the Churg-Strauss syndrome | Q41343655 | ||
| Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome | Q42955730 | ||
| Rituximab in Churg-Strauss syndrome. | Q42956093 | ||
| Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}. | Q43048537 | ||
| Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales | Q43722450 | ||
| Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists | Q44580567 | ||
| Clinical and immunological effects of low-dose IFN-alpha treatment in patients with corticosteroid-resistant asthma | Q44654747 | ||
| Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis | Q44772811 | ||
| Unusual presentation of temporal bone involvement in Churg-Strauss syndrome | Q45210593 | ||
| Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab | Q46504507 | ||
| Churg-Strauss vasculitis in a patient treated with omalizumab | Q46694058 | ||
| Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients | Q46830093 | ||
| Churg-Strauss syndrome presenting with salivary gland enlargement and respiratory distress | Q47641567 | ||
| Multiple tracheobronchial mucosal lesions in two cases of Churg-Strauss syndrome | Q47653932 | ||
| Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis | Q47682561 | ||
| Asthma drug use and the development of Churg-Strauss syndrome (CSS). | Q50183433 | ||
| Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. | Q50657166 | ||
| Acute painless monocular visual loss due to central retinal artery occlusion in a patient with Churg-Strauss vasculitis. | Q50684242 | ||
| Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome. | Q51964505 | ||
| Increased serum vascular endothelial growth factor level in Churg-Strauss syndrome. | Q53636598 | ||
| The American College of Rheumatology 1990 criteria for the classification of churg-strauss syndrome (allergic granulomatosis and angiitis) | Q56433277 | ||
| Increased serum high mobility group box-1 level in Churg-Strauss syndrome | Q56744136 | ||
| Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome | Q58051633 | ||
| Treatment of Churg-Strauss syndrome without poor-prognosis factors: A multicenter, prospective, randomized, open-label study of seventy-two patients | Q59400054 | ||
| Associations of Churg-Strauss syndrome with the HLA–DRB1 locus, and relationship to the genetics of antineutrophil cytoplasmic antibody–associated vasculitides: Comment on the article by Vaglio et al | Q60689134 | ||
| Eotaxin-3 is involved in Churg-Strauss syndrome - a serum marker closely correlating with disease activity | Q61628436 | ||
| Marked improvement of Churg-Strauss vasculitis with intravenous gamma globulins during pregnancy | Q64045791 | ||
| Churg-Strauss syndrome | Q73029473 | ||
| Are environmental factors important in primary systemic vasculitis? A case-control study | Q73114838 | ||
| Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients | Q73661498 | ||
| Eosinophil active cytokines and surface analysis of eosinophils in Churg-Strauss syndrome | Q74604086 | ||
| Efficacy of the anti-TNF-alpha antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients | Q78328605 | ||
| Churg-Strauss syndrome | Q79401345 | ||
| Cerebral venous thrombosis as a rare onset of Churg-Strauss syndrome | Q79811169 | ||
| Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: Remission, relapse, and re-treatment | Q80201632 | ||
| Administration of anti-IgE to a Churg-Strauss syndrome patient | Q80401124 | ||
| Conjunctival involvement in Churg-Strauss syndrome | Q80454691 | ||
| One year administration of anti-IgE to a patient with Churg-Strauss syndrome | Q80513103 | ||
| Development of Churg-Strauss syndrome with controlled asthma during omalizumab treatment | Q80517573 | ||
| Churg-Strauss syndrome triggered by hyposensitization to Alternaria fungus | Q80732474 | ||
| HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome | Q80974132 | ||
| Images in cardiovascular medicine. Magnetic resonance assessment and therapy monitoring of cardiac involvement in Churg-Strauss syndrome | Q80987039 | ||
| Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome | Q81097632 | ||
| P433 | issue | 6 | |
| P921 | main subject | Churg-Strauss syndrome | Q32811 |
| P304 | page(s) | 453-458 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Current Rheumatology Reports | Q23930052 |
| P1476 | title | Churg-Strauss syndrome: 2005-2008 update | |
| P478 | volume | 10 |
| Q37529934 | A Rare Right Ventricular Involvement of Eosinophilic Granulomatosis Demonstrated by Cardiac MRI. |
| Q33575466 | Asthma that is unresponsive to usual care |
| Q44838612 | Bilateral subconjunctival masses as a rare presentation of Churg-Strauss syndrome |
| Q35436406 | Cardiac involvement of churg-strauss syndrome as a reversible cause of dilated cardiomyopathy |
| Q47119150 | Churg-Straus syndrome: A case report |
| Q30110869 | Combined effects of hypoxia and hypercapnia on the functional state of the respiratory center |
| Q34156332 | Diagnosis and treatment of cerebral vasculitis |
| Q43430672 | Lesson of the month. (1). What lies beneath the surface? Diagnosis. Churg-Strauss syndrome. |
| Q42193273 | Leukocytoclastic vasculitis: a window to systemic churg strauss syndrome |
| Q38063147 | Skin involvement in ANCA-associated vasculitis |
| Q37566353 | Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood |
Search more.